FT Options’s Amgen AMGN Stock Holding History

FT Options’s Portfolio AMGN Stock Details AMGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q3	–	Sell	-12,082	Closed	-$2.08M	–	230
2017 Q2	$2.08M	Buy	+12,082	New	+$1.97M	3.58%	8
2016 Q1	–	Sell	-9,400	Closed	-$1.4M	–	292
2015 Q4	$1.53M	Buy	+9,400	New	+$1.48M	1.13%	28

Other funds holding AMGN

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

FT Options's AMGN Position: Q3 2017 in Review

FT Options sold out of Amgen (AMGN) in Q3 2017, closing a stake of 12,082 shares — an estimated $2.08M sold.

FT Options first reported a position in AMGN in Q4 2015 and held it in 2 quarters. The position peaked at $2.08M in Q2 2017. 1,605 funds tracked by Wall St. Rank hold AMGN as of Q3 2017.

FT Options reported no remaining Amgen position as of Q3 2017 after selling out during the quarter.
FT Options sold 12,082 Amgen shares in Q3 2017, an estimated $2.08M.
FT Options first reported a position in Amgen in Q4 2015 and held it in 2 quarters.
FT Options's Amgen position peaked at $2.08M in Q2 2017.
1,605 funds tracked by Wall St. Rank held Amgen as of Q3 2017.

Based on FT Options's 13F filing for Q3 2017, filed 13 Nov 2017.